Recently patented transcatheter aortic valves in clinical trials

Recent Patents on Cardiovascular Drug Discovery

Volumn 8, Issue 3, 2013, Pages 186-191

  Neragi Miandoab, Siyamek ^a   Skripochnik, Edvard ^a   Salemi, Arash ^a   Girardi, Leonard ^a  

^a Department of Cardiothoracic Surgery Weil Cornell University Hospital College of Medicine ^*  (United States)

Author keywords

Direct flow medical; Jenavalve; Medtronic engager; Portico aortic valve; Sadra medical; Self expanding valves; Symetis; Transapical approach; Transcatheter aortic valve implantation; Transfemoral approach

Indexed keywords

AORTA VALVE PROSTHESIS; ARTICLE; CLINICAL TRIAL; EQUIPMENT DESIGN; HUMAN; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; CLINICAL TRIAL (TOPIC); HEART VALVE PROSTHESIS; PATENT; PROCEDURES;

CLINICAL TRIALS AS TOPIC; HEART VALVE PROSTHESIS; HUMANS; PATENTS AS TOPIC; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84900806462     PISSN: 15748901     EISSN: 22123962     Source Type: Journal    
DOI: 10.2174/1574890108666131126145250     Document Type: Article

References (30)

1. Lashinski, R.T. Percutaneous heart valve with stentless support. US7641686 (2010).
2. Chodor P, Wilczek K, Przybylski R, Krason M, Glowacki J, Niklewski T, et al. Immediate and 6-month outcomes of transapical and transfemoral Edwards-Sapien prosthesis implantation in patients with aortic stenosis. Kardiologia Polska 2010; 68:1124-31
3. Vaturi M, Porter A, Adler Y, Shapira Y, Sahar G, Vidne B, et al. The natural history of aortic valve disease after mitral valve surgery. J Amer College Cardiol 1999; 33: 2003-2008
4. Bande M, Michev I, Sharp AS, Chieffo A, Colombo A. Percutaneous transcatheter aortic valve implantation: Past accomplishments, present achievements and applications, future perspectives. Cardiol Rev 2010; 18: 111-24.
5. Azadani AN, Jaussaud N, Matthews PB, Ge, L, Guy TS, Chuter T A, et al. Valve-in-valve implantation using a novel supravalvular transcatheter aortic valve: proof of concept. Ann Thorac Surg 2009; 88: 1864-9.
6. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: Why are so many denied surgery?, Eur Heart J 2005; 26: 2714-20.
7. Varadarajan P Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-5.
8. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circul Cardiovasc Quality Outcomes 2009; 2:533-9.
9. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-8
10. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Eng J Med 2010; 363: 1597-607
11. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Eng J Med 2010; 364: 2187-98
12. Sinning JM, Walenta K, Werner N, Bohm M. Hotline update of clinical trials and registries presented at the 77th spring meeting of the German Society of Cardiology 2011, Clinical research in cardiology: official journal of the German Cardiac Society 2011; 100: 553-560
13. Neragi-Miandoab S, Mohr FW, Borger MA, Holzhey DM Transapical implantation of an Edwards Sapien valve into a failed prosthetic mitral valve 3 years after a transapical aortic valve implantation. J Thorac Cardiovasc Surg 2013; 145:e19-21
14. Neragi-Miandoab S, Michler RE. A review of most relevant complications of transcatheter aortic valve implantation. ISRN Cardiol 2013; 2013: 956252
15. Zhang, J., Burnaby, C. Methods and devices for transapical delivery of a sutureless valve prosthesis. US8366767 (2010).
16. Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema CSJ, Scheer AC, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Amer College Cardiol 2012; 59:1134-41
17. Neragi-Miandoab S, Skripochnik E, Michler RE. Recently patented and widely used valves for transcatheter aortic valve implantation. Rec Pat Cardiovasc Drug Discov 2012; 7:196-205
18. Figulla, H. R., Ferrari, M. Self-expandable medical instrument for treating defects in a patient's heart. US8062355 (2011).
19. Willson AB, Rodes-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico Valve: First-in-human experience. J Amer College Cardiol 2012; 60: 581-6
20. Salahieh, A., Brandt, B., Geshlider, R. A., Morejohn, D. P., Saul, T. Leaflet engagement elements and methods for use thereof. US8343213 (2004).
21. Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis, Catheterization and cardiovascular interventions. Official J Soc Cardiac Angiography & Intervent 2008; 71: 579-84.
22. Del Valle-Fernandez R, Ruiz CE. Transcatheter heart valves for the treatment of aortic stenosis: state-of-the-art. Minerva Cardioangiologica 2008; 56: 543-56.
23. Bolling SF, Rogers JH, Babaliaros V, Piazza N, Takeda PA, Low RI, et al. Percutaneous aortic valve implantation utilising a novel tissue valve: preclinical experience, EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008; 4:148-153
24. Bijuklic K, Tuebler T, Reichenspurner H, Treede H, Wandler A, Harreld JH, et al. Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot study. Circul Cardiovasc Intervent 2011; 4: 595-601
25. Schofer J, Schluter M, Treede H, Franzen OW, Tubler T, Pascotto A, et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: A first-in-man feasibility and safety study. Circul Cardiovasc Intervent 2008; 1: 126-33.
26. Treede H, Tubler T, Reichenspurner H, Grube E, Pascotto A, Franzen O, et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: The direct flow medical aortic valve. J Thorac Cardiovasc Surg 2010; 140: 897-903
27. Bijuklic K, Tubler T, Low RI, Grube E, Schofer J. Direct flow medical valve, eurointervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2012; 8 (Suppl Q):Q75-78
28. Low RI, Bolling SF, Yeo KK, Ebner A. Direct flow medical percutaneous aortic valve: proof of concept. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008; 4:256-61.
29. Lauten A, Ferrari M, Petri A, Ensminger SM, Gummert JF, Boudjemline Y, et al. Experimental evaluation of the JenaClip transcatheter aortic valve, Catheterization and cardiovascular interventions. Official J Soc Cardiac Angiogr Intervent 2009; 74: 514-9
30. Kempfert J, Rastan AJ, Mohr FW, Walther TA. new selfexpanding transcatheter aortic valve for transapical implantation-first in man implantation of the JenaValve, European journal of cardio-thoracic surgery. Official J Eur Ass Cardio-Thorac Surg 2011; 40:761-3.